Legislation and Supporting Documents Practice Resources Pharmacy Technicians Expanded Scope of Practice Forms & Pharmacy Signs Implementation of the December 2006 Pharmaceutical Act

Pharmacy Practice

The College of Pharmacists of Manitoba (formerly known as the “Manitoba Pharmaceutical Association”) continues to adapt the content on www.cphm.ca in order to reflect the December 2006 Pharmaceutical Act , implemented January 1, 2014. The documents on the website with “Manitoba Pharmaceutical Association” or “MPhA” have not been updated and may not be consistent with the current legislation. Questions on this content can be directed to the College office.


Legislation and Supporting Documents


Orientation to the New Practice Framework (updated January 19, 2014

This manual was developed to help answer questions around the new Act, July 2013 Regulations
and practice directions implemented January 1, 2014.

December 2006 the Pharmaceutical Act
(posted January 3, 2014)

Manitoba Pharmaceutical Regulation (July 2013) (posted January 3, 2014) - NOTE: Government to amalgamate with Pharmaceutical Regulation, amendment (see next item)

Manitoba Pharmaceutical Regulation, amendment (posted September 30, 2016) - NOTE: Government to amalgamate with Pharmaceutical Regulation (see item above)

Manitoba By-Laws to The Pharmaceutical Act

Code of Ethics (January 1, 2014)     
The Code of Ethics governs the conduct of members, students, interns and owners. 

Prescription Drug Cost Assistance Act

Outline of Prescription Drug Regulations

Outline of M3P Prescription Drug Regulations

Prescription Drugs Payment of Benefits Regulation

Manitoba Drug Benefits and Interchangeability Formulary

Manitoba Drug Benefits and Interchangeability Formulary List

The Apology Act

The Fair Registration Practices Act

Non-Potable Intoxicating Substances, Stomach Bitters and Rubbing Alcohol Regulation

Non-Smokers Health Protection Amendment Act

Pharmaceutical (General Matters) Regulation (in which a pharmacist is designated as a practitioner) (posted March 4, 2014)

Personal Health Information Act and Regulations   

The Protection for Persons in Care Act

Minimum Pharmacy Policy and Procedures Manual Content

Workplace Safety and Health Act

The Public Health Act and Regulations


Food and Drugs Act & Regulations

Controlled Drugs and Substances Act
& Regulations

Narcotic Control Regulations

Health Canada Prescription Drug List

Section 56 Class Exemption


Prescribing Authority Table  

Clinical & Physician Assistants

Clinical & Physician Assistant: Prescribing Authority (updated November 2016)
For a list of Clinical and Physician Assistants, please click here.


For an updated list of Dentists, please click here. [To be updated]


The Midwifery Act

Medications & Devices that a Midwife May Prescribe & Administer (Schedule B to the Midwifery Regulations of The Midwifery Act)

For a list of Midwives, please click here.


Prescribing Authority for Pharmacists

Available Drugs for Prescribing under Schedule 3 to the Manitoba Pharmaceutical Regulation


For the Physician Directory, Currently Licensed and Practising in the Province please click here .

Registered Nurses (Extended Practice)

RN(EP) (Extended Practice Registered Nurses) and NP (Nurse Practitioners)

have expanded prescriptive authority

View the CRNM Nurse Check (Extended Practice)

Letter to Manitoba Pharmacists from CRNM.


For a list of Veterinarians, please click here.


Optometrists Prescribing Authority (June 4, 2015)

Optometrists Drug List (Schedule A) 

To verify an Optometrist's therapeutic licence, please click here .

Standards of Practice and Practice Directions

A practice direction is a written statement made by Council for the purpose of giving direction to members and owners about the conduct of their practice and pharmacy operations. Compliance with approved practice directions is required under The Pharmaceutical Act .    

Practice Directions Policy Statement

National Association of Pharmacy Regulatory Authorities (NAPRA) Model Standards 

For more information about the National Association of Pharmacy Regulatory Authorities (NAPRA) and the documents listed below, please visit their website at napra.ca .

NAPRA Model Standards of Practice for Canadian Pharmacists [practice direction]

NAPRA Supplemental Standards of Practice for Shedule II and III Drugs [practice direction]

Model Standards for Pharmacy Compounding of Non-Hazardous Sterile Preparations [not yet in effect]

Model Standards for Pharmacy Compounding of Hazardous Sterile Preparation [not yet in effect]

PLEASE NOTE:  In November 2016, NAPRA made a revision to the Model Standards for Pharmacy Compounding of Non-Hazardous Preparations and to the Model Standards for Pharmacy Compounding of Hazardous Sterile Preparations.  Specifically, the reference to  Sterilization by Filtration  in the  Glossary of each document now reflects the correct reference to USP797 of  30 psi not 50 psi as previously published.

The effective dates for the Non-Hazardous and Hazardous Sterile Preparations  standards documents listed above will be determined by College Council.

Model Standards for Pharmacy Compounding of Non-Sterile Preparations [out for consultation]

Interim Standards of Practice and Practice Directions 

In 2011, Council made the decision to accept the then current Standards of Practice documents as practice directions under the new legislation in order for the Standards of Practice Committee to focus on the creation of new practice directions that were needed under the new regulations and expanded scope of practice for pharmacists. The Standards of Practice listed below are now considered "practice directions" and will be reviewed by the Standards of Practice Committee in due course. 

Community Standards of Practice [practice direction]

Hospital Standards of Practice and Guidelines [practice direction] 

Personal Care Home - Long-Term Care Standards of Practice [practice direction]

Approved Standards of Practice and Practice Directions

After a series of Special General Meetings and opportunities for member feedback, as per the Practice Directions Policy Statement, the following practice directions have been approved by Council.

Adaptation of a Prescription
[effective January 1, 2014]

Administration of Drugs including Vaccines [Standard of Practice #5 [updated and posted June 25, 2014]

Advertising in Manitoba Pharmacies [effective February 8, 2016]

Alternate Verification Program: Drug Packaging [effective April 24, 2015]

Central Fill [effective April 11, 2014]

Clinical Practice Pharmacies Practice Direction [effective October 5, 2015]

Delegation of Dispensing to Other Health Professionals Practice Direction [effective December 18, 2015]

Drug Distribution Practice Direction [effective July 8, 2016]

Ensuring Patient Safety [updated document is effective March 13, 2015]

Exempted Codeine Practice Direction [effective February 1, 2016]

Aids to the Exempted Codeine Practice Direction: 

Incidents and Discrepancies Practice Direction [effective July 8, 2016]

Lock and Leave Component [effective January 1, 2014]

Manitoba Prescribing Practices Program (M3P) Information Entered into DPIN [effective January 1, 2014]

Pharmacy Facilities [Standard of Practice #15] [effective January 1, 2014]

Patient Counselling [effective October 10, 2014]

Patient Profiles [effective October 10, 2014]

Permanent and Temporary Pharmacy Closure   [effective July 4, 2014]

Prescribing [amended October 6, 2014]

Prescribing and Dispensing [Standard of Practice #4] [effective January 1, 2014]

Records and Information [Standard of Practice #12] [effective January 1, 2014]

Referring a Patient

Refill History Recording System [effective February 13, 2015]

Sale of Schedule 2 Drugs [effective January 1, 2014]

Sale of Schedule 3 Drugs [effective January 1, 2014]

Secondary Hospital Services Component Practice Direction [effective December 18, 2015]

Termination of Patient Relationship [Standard of Practice #11] [effective July 4, 2014]

Test Interpretation [Standard of Practice #7] [effective January 1, 2014]

Transfer of Patient care [Standard of Practice #10] [effective January 1, 2014]

Supervision [effective July 4, 2014]

 *This practice direction serves as a guideline for pharmacy managers considering submission of a proposal for Council approval to implement an Alternate Verification Program in their pharmacy. Please be advised that pharmacy managers must receive prior approval by Council of their proposal before an Alternate Verification Program can be initiated in their pharmacy.

Draft Practice Directions Open for Member Consultation and Feedback

A Practice Direction is a written statement made by Council for the purposes of giving direction to members and owners about the conduct of their practice and pharmacy operations. Before a Practice Direction is approved by Council, members are provided with the opportunity to review and provide their feedback on draft practice directions, for consideration at Council. Compliance with approved Practice Directions is required under The  Pharmaceutical Act .

There are no Practice Directions currently open for member feedback.


Practice Guidelines

On April 25, 2014, Council passed a motion to accept the document’s proposed requirements for the PPMS used by pharmacy professionals for compliance in Manitoba pharmacies by January 1, 2016, in conjunction with NAPRA’s effective date. The following guidelines are approved by Council. They are policies and practice indicators developed under the old legislation and are still valid under the new legislation. These documents will be reviewed by Council in due course.

Adverse Drug Reaction Guidelines

Extemporaneous Compounding Guidelines- MPhA 
Guidelines for the Pre-filling of Insulin Syringes [To be updated] 

Guidelines for Pharmacists Dispensing Mifegymiso in Manitoba

Guidelines for pharmacy licence holders wanting to use more than one name for their pharmacy 

Guidelines on sterile production in pharmacies, and handling and disposal of hazardous pharmaceuticals 

Narcotic and Controlled Drug Accountability Guidelines

Needle Stick Injury Guideline (added June 30, 2015)

Procedures in the Event of a Robbery or Burglary [updated December 2014]

Satellite  Pharmacy Component Criteria

Self-Testing Product Guidelines

Practice Direction for Advertising* 

* Requested by Council to be revised and transitioned by the Standards of Practice Committee with consultation by the members and stakeholders. Consultation has closed and Council has referred feedback received on this practice direction consultation to the Standards of Practice Committee for further review and consideration and asked the  Registrar to provide additional information for the consideration of the Committee.  

 Opioid Replacement Therapy Guidelines for Manitoba Pharmacists

The Opioid Replacement Therapy Guidelines for Manitoba Pharmacists (ORT Guidelines) replaces Principles for the Provisions Opioid Dependence Treatment by Manitoba Pharmacists Guidelines.

ORT Guidelines is a new title that corresponds with the interprofessional Opioid Replacement Therapy 101 workshop which is required education for at least one pharmacist at each pharmacy that is dispensing methadone or buprenorphine. Other changes include:

  • More comprehensive drug information and updated education requirements on buprenorphine/naloxone as the use of this medication has increased with new provincial drug coverage
  • Updated information from Provincial Drug Programs for methadone reimbursement procedures

All pharmacists who have patients at their pharmacy on buprenorphine/naloxone or buprenorphine must complete the free six-hour professional development program available online at www.suboxone.ca

Additional recommended readings for pharmacists dispensing opioid replacement therapy include:

If you are interested in taking an Opioid Replacement Therapy workshop, please contact Karen Sorenson at College of Physician and Surgeons of Manitoba (CPSM) by email: ksorenson@cpsm.mb.ca.
For additional resources on dispensing and administering naloxone please review the section below.


Manitoba, along with the rest of Canada, has seen a rise in the number of opioid overdose deaths in recent years. As a result, some pharmacies in the province have begun selling naloxone kits and providing education to people and organizations in need of this life-saving drug that can temporarily reverse the effects of an overdose.

The College encourages all pharmacies to carry naloxone kits to support the province-wide effort to address the opioid crisis. Pharmacies selling naloxone must comply with the Guidelines for Pharmacists Selling Naloxone as a Schedule II Drug   (Guidelines).

Please review the Guidelines for more information about selling naloxone, including:

  • Training requirements

  • Relevant practice directions

  • Patient counselling

If your pharmacy carries naloxone kits and you would like to be added to the publically available College listing of Pharmacies Carrying Naloxone Kits , please email your pharmacy's name, address, and telephone number to Rachel Carlson, Communications Coordinator, at rcarlson@cphm.ca

For additional information and resources on opioid overdose and naloxone, please see the resources below:

External Resources:

Overdose and Prevention Response Training Manual

Street Connections: Overdose Naloxone Saves Lives, Hello Cool World  (video)

Manitoba Addictions and Knowledge Exchange: Fentanyl - Information and Resources

University of Waterloo, School of Pharmacy Resources

Naloxone Administration  (by injection) (video) 

Naloxone Administration  (by nasal spray) (video) 

5 Things to Know About Naloxone  (video) 

Giving Naloxone  (video)

College of Pharmacists of Manitoba Resources:

Naloxone Listing - College of Pharmacists of Manitoba   

College of Pharmacists of Manitoba Checklist for Naloxone Injection Training

College of Pharmacists of Manitoba Checklist for Naloxone Nasal Spray

Naloxone Brochure for Ampoules (black and white)

Naloxone Brochure for Ampoules (colour)

College of Pharmacists of Manitoba Naloxone FAQ 

The Naloxone educational information included above was developed through a partnership between the College of Pharmacists of BC, the BC Centre of Disease Control and the Province of BC's Ministry of Health.

This work is licensed under a  Creative Commons Attribution-ShareAlike 4.0 International License .

The naloxone educational resources above are available under the Creative Commons Attribution-ShareAlike License to use and remix as needed to help provide patients and pharmacy professionals with important information on the use of this life saving drug. 

  Medical Assistance In Dying (MAID) (formerly physician assisted dying)

Notice to Pharmacy Managers and Pharmacists

Emergency Contraception 

Emergency Contraception Care Guidelines 

Duty of Pharmacists to Report Issues in the Course of Counseling and Providing Emergency Contraception Care for Minors

  Manitoba Prescribing Practices Program (M3P)

Manitoba Prescribing Practices Program (M3P Information Entered into DPIN Practice Direction 

M3P Questions and Answers [updated August, 2016] 

List of Drugs Covered by the Multiple Prescription Program 

Regulations Governing the Multiple Prescription Program 

Prescriptions from other Provinces 

Newsletter Items Relating to M3P 

M3P DPIN Entry Information 

Emergency Preparedness

Emergency Preparedness Resource Kit for Pharmacists

Field Office Information

Permanent and Temporary Pharmacy Closure [effective July 4, 2014]

New Pharmacy Opening Package [for 2016]

Procedures in the Event of a Robbery or Burglary

Prescription Forgeries [from the Summer 2013 Newsletter]

PHIA Pledge of Confidentiality

Distance Care IPS Disclaimer

Manitoba Medications Return Program Website

Manitoba Medication Return Program FAQ [updated November 3, 2014]

Frequently Asked Questions: Patient Record Destruction  

Joint Statements

Healthcare professionals from various disciplines, including pharmacy, are often jointly involved in the care of a common patient even though individual professionals are not in direct contact with one another. Joint statements are developed between healthcare professions to maintain patient safety and ensure collaborative patient care. 

Prescribing Practices: Doctor/Pharmacist Relationships  (updated to reflect the requirement for retention of records for five years)

Facsimile Transmission of Prescriptions

Facsimile Transmission of Prescriptions Template  (pdf template)

Facsimile Transmission of Prescriptions Template  (word template)

Q and A: Electronic and Facsimile Transmission of Prescriptions